Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 8.12 SEK -0.37% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Vicore Pharma Holding AB
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vicore Pharma Holding AB
Research & Development Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Vicore Pharma Holding AB
STO:VICO
Research & Development
-kr275m
CAGR 3-Years
-26%
CAGR 5-Years
-65%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Research & Development
-kr104.4m
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Research & Development
-kr71.7m
CAGR 3-Years
-23%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Research & Development
-kr115m
CAGR 3-Years
-13%
CAGR 5-Years
-6%
CAGR 10-Years
-8%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Research & Development
-kr3.3B
CAGR 3-Years
-32%
CAGR 5-Years
-18%
CAGR 10-Years
-22%
BioArctic AB
STO:BIOA B
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Vicore Pharma Holding AB's Research & Development?
Research & Development
-275m SEK

Based on the financial report for Jun 30, 2024, Vicore Pharma Holding AB's Research & Development amounts to -275m SEK.

What is Vicore Pharma Holding AB's Research & Development growth rate?
Research & Development CAGR 5Y
-65%

Over the last year, the Research & Development growth was -20%. The average annual Research & Development growth rates for Vicore Pharma Holding AB have been -26% over the past three years , -65% over the past five years .

Back to Top